Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-12

Clinical Trial Update: COGSCREEN II: Early Detection of Cognitive Impairment [NA]

View source ↗

Summary

This is a clinical trial update for COGSCREEN II, a study on early detection of cognitive impairment in Alzheimer's disease. It is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Robert Perneczky | Conditions: Alzheimer's Disease (AD) | NA | Status: RECRUITING